CHICAGO-"Drive-thru" deliveries may be responsible for an increase in a rare condition that causes brain damage. Babies who are sent home a day after birth may not be treated for jaundice, which can lead to kernicterus.
Kernicterus, which was common in the 1940s and 1950s, has become rare in the last several decades. The condition can cause several cerebral palsy, hearing loss, teeth malformations, and other malformations.
Kernicertus is caused when the brain receives too many bilirubin cells. The liver is supposed to filter these cells out of the blood stream; however, most infants' livers do not begin working for several days after their birth. Jaundice, which is causes a yellowing of the skin, involves an elevated level of bilirubin. Jaundiced babies are often placed under fluorescent lights that make these cells more easily filtered by the liver.
Babies sent home healthy may still develop jaundice. If untreated, this can cause kernicertus.
Doctors are not certain how bilirubin damages the brain, but autopsies of infants with the disease have found yellow staining the region of the brain that controls movement. Kernicterus is not monitored by the Centers for Disease Control and Prevention (CDC), however the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) is asking healthcare workers to monitor jaundice more carefully to protect infants. The commission recommends that all newborns with jaundice receive medical follows-ups within two days after being sent home. Parents should also be educated about jaundice and the risks associated.
Information from www.arizonarepublic.com
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
Robust infectious disease surveillance, including rapid subtyping of influenza A, is essential for early detection, containment, and public health reporting of novel viral threats.